C. Eymin

发表

Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in pregnant women: a randomized, observer-blind trial

T. Vesikari, S. Heinonen, M. Virta, 2019, Human vaccines & immunotherapeutics.

Concomitant administration of a fully liquid ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal ACWY conjugate vaccine in toddlers.

S. Lockhart, T. Vesikari, F. Boisnard, 2018, Vaccine.

Immunogenicity and safety of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Tdap-IPV; Repevax) administered concomitantly versus non-concomitantly with an influenza vaccine (Vaxigrip) to adults aged ≥60 years: an open-label, randomised trial.

M. Baudin, B. Soubeyrand, G. Gavazzi, 2013, Vaccine.

Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: a randomised non-inferiority clinical trial.

J. García de Lomas, J. Díez-Domingo, T. Weinke, 2015, Vaccine.

Enhanced passive safety surveillance of three marketed influenza vaccines in the UK and the Republic of Ireland during the 2017/18 season

K. Butler, A. Moureau, Anne-Laure Chabanon, 2019, Human vaccines & immunotherapeutics.

Immunogenicity and safety of concomitant administration of a measles , mumps and rubella vaccine ( MM-RvaxPro ® ) and a varicella vaccine ( VARIVAX ® ) by intramuscular or subcutaneous routes at separate injection sites : a randomised clinical trial

S. Thomas, Y. Gillet, A. Fiquet, 2015 .

Immunogenicity and safety of concomitant administration of a measles, mumps and rubella vaccine (M-M-RvaxPro®) and a varicella vaccine (VARIVAX®) by intramuscular or subcutaneous routes at separate injection sites: a randomised clinical trial

S. Thomas, Y. Gillet, A. Fiquet, 2009, BMC medicine.

Immunogenicity and safety of a combined measles, mumps, rubella and varicella live vaccine (ProQuad ®) administered concomitantly with a booster dose of a hexavalent vaccine in 12-23-month-old infants.

K. Deichmann, M. Baudin, S. Thomas, 2015, Vaccine.

Persistence of immunity in healthy adults aged ≥50 years primed with a hepatitis B vaccine 3 years previously

C. Ahlm, Rajiv Sharma, S. Thomas, 2015, Human vaccines & immunotherapeutics.

Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy.

S. Lockhart, A. Zanetti, B. Soubeyrand, 2017, Vaccine.

Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy.

S. Lockhart, A. Zanetti, B. Soubeyrand, 2017, Vaccine.